Cargando…
Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review
Type 1 diabetes mellitus is a chronic autoimmune disease that affects millions of people and generates high healthcare costs due to frequent complications when inappropriately managed. Our paper aimed to review the latest technologies used in T1DM management for better glycemic control and their imp...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456000/ https://www.ncbi.nlm.nih.gov/pubmed/37629520 http://dx.doi.org/10.3390/life13081663 |
_version_ | 1785096590081392640 |
---|---|
author | Elian, Viviana Popovici, Violeta Ozon, Emma-Adriana Musuc, Adina Magdalena Fița, Ancuța Cătălina Rusu, Emilia Radulian, Gabriela Lupuliasa, Dumitru |
author_facet | Elian, Viviana Popovici, Violeta Ozon, Emma-Adriana Musuc, Adina Magdalena Fița, Ancuța Cătălina Rusu, Emilia Radulian, Gabriela Lupuliasa, Dumitru |
author_sort | Elian, Viviana |
collection | PubMed |
description | Type 1 diabetes mellitus is a chronic autoimmune disease that affects millions of people and generates high healthcare costs due to frequent complications when inappropriately managed. Our paper aimed to review the latest technologies used in T1DM management for better glycemic control and their impact on daily life for people with diabetes. Continuous glucose monitoring systems provide a better understanding of daily glycemic variations for children and adults and can be easily used. These systems diminish diabetes distress and improve diabetes control by decreasing hypoglycemia. Continuous subcutaneous insulin infusions have proven their benefits in selected patients. There is a tendency to use more complex systems, such as hybrid closed-loop systems that can modulate insulin infusion based on glycemic readings and artificial intelligence-based algorithms. It can help people manage the burdens associated with T1DM management, such as fear of hypoglycemia, exercising, and long-term complications. The future is promising and aims to develop more complex ways of automated control of glycemic levels to diminish the distress of individuals living with diabetes. |
format | Online Article Text |
id | pubmed-10456000 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104560002023-08-26 Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review Elian, Viviana Popovici, Violeta Ozon, Emma-Adriana Musuc, Adina Magdalena Fița, Ancuța Cătălina Rusu, Emilia Radulian, Gabriela Lupuliasa, Dumitru Life (Basel) Review Type 1 diabetes mellitus is a chronic autoimmune disease that affects millions of people and generates high healthcare costs due to frequent complications when inappropriately managed. Our paper aimed to review the latest technologies used in T1DM management for better glycemic control and their impact on daily life for people with diabetes. Continuous glucose monitoring systems provide a better understanding of daily glycemic variations for children and adults and can be easily used. These systems diminish diabetes distress and improve diabetes control by decreasing hypoglycemia. Continuous subcutaneous insulin infusions have proven their benefits in selected patients. There is a tendency to use more complex systems, such as hybrid closed-loop systems that can modulate insulin infusion based on glycemic readings and artificial intelligence-based algorithms. It can help people manage the burdens associated with T1DM management, such as fear of hypoglycemia, exercising, and long-term complications. The future is promising and aims to develop more complex ways of automated control of glycemic levels to diminish the distress of individuals living with diabetes. MDPI 2023-07-30 /pmc/articles/PMC10456000/ /pubmed/37629520 http://dx.doi.org/10.3390/life13081663 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Elian, Viviana Popovici, Violeta Ozon, Emma-Adriana Musuc, Adina Magdalena Fița, Ancuța Cătălina Rusu, Emilia Radulian, Gabriela Lupuliasa, Dumitru Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review |
title | Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review |
title_full | Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review |
title_fullStr | Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review |
title_full_unstemmed | Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review |
title_short | Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review |
title_sort | current technologies for managing type 1 diabetes mellitus and their impact on quality of life—a narrative review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456000/ https://www.ncbi.nlm.nih.gov/pubmed/37629520 http://dx.doi.org/10.3390/life13081663 |
work_keys_str_mv | AT elianviviana currenttechnologiesformanagingtype1diabetesmellitusandtheirimpactonqualityoflifeanarrativereview AT popovicivioleta currenttechnologiesformanagingtype1diabetesmellitusandtheirimpactonqualityoflifeanarrativereview AT ozonemmaadriana currenttechnologiesformanagingtype1diabetesmellitusandtheirimpactonqualityoflifeanarrativereview AT musucadinamagdalena currenttechnologiesformanagingtype1diabetesmellitusandtheirimpactonqualityoflifeanarrativereview AT fitaancutacatalina currenttechnologiesformanagingtype1diabetesmellitusandtheirimpactonqualityoflifeanarrativereview AT rusuemilia currenttechnologiesformanagingtype1diabetesmellitusandtheirimpactonqualityoflifeanarrativereview AT raduliangabriela currenttechnologiesformanagingtype1diabetesmellitusandtheirimpactonqualityoflifeanarrativereview AT lupuliasadumitru currenttechnologiesformanagingtype1diabetesmellitusandtheirimpactonqualityoflifeanarrativereview |